Shares of Merck KGaA (OTCMKTS:MKGAF – Get Free Report) were down 7.8% on Thursday . The stock traded as low as $135.95 and last traded at $135.95. Approximately 215 shares were traded during trading, a decline of 64% from the average daily volume of 603 shares. The stock had previously closed at $147.49.
Merck KGaA Price Performance
The company has a market cap of $18.47 billion, a price-to-earnings ratio of 21.82 and a beta of 0.96. The stock has a 50 day simple moving average of $131.55 and a two-hundred day simple moving average of $139.53. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
- MarketBeat Week in Review – 05/11 – 05/15
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
